FN1 and colorectal cancer: Neutrophil membrane‐based drug delivery, leveraging inflammatory chemotaxis, holds promise for treating Fn‐infiltrated colorectal cancer.[36, 37] Furthermore, our results demonstrated that Fn gavage promoted the expression of adhesion molecules, which provided powerful support for Neutrophil membrane‐based drug delivery to effectively target and bind to tumor cells.